6065 related articles for article (PubMed ID: 3023762)
21. Interleukin 1 (IL 1)-dependent lymphokine production by human leukemic T cell line HSB.2 subclones.
Kasahara T; Mukaida N; Hatake K; Motoyoshi K; Kawai T; Shiori-Nakano K
J Immunol; 1985 Mar; 134(3):1682-9. PubMed ID: 3871456
[TBL] [Abstract][Full Text] [Related]
22. Macrophage activation for tumor cytotoxicity: induction of macrophage tumoricidal activity by lymphokines from EL-4, a continuous T cell line.
Meltzer MS; Benjamin WR; Farrar JJ
J Immunol; 1982 Dec; 129(6):2802-7. PubMed ID: 6982943
[TBL] [Abstract][Full Text] [Related]
23. Multiple and heterogeneous patterns of cytokine production in 18 leukemia and in vitro transformed mature T cell lines reflect the individuality of human leukemias.
Dao T; Holán V; Minowada J
Int J Hematol; 1993 Apr; 57(2):139-46. PubMed ID: 8494992
[TBL] [Abstract][Full Text] [Related]
24. Molecular mechanisms involved in T cell activation. I. Evidence for independent signal-transducing pathways in lymphokine production vs proliferation in cloned cytotoxic T lymphocytes.
Harris DT; Kozumbo WJ; Cerutti P; Cerottini JC
J Immunol; 1987 Jan; 138(2):600-5. PubMed ID: 3540123
[TBL] [Abstract][Full Text] [Related]
25. Macrophages as effector cells of protective immunity in murine schistosomiasis. VI. T cell-dependent, lymphokine-mediated, activation of macrophages in response to Schistosoma mansoni antigens.
James SL; Lazdins JK; Hieny S; Natovitz P
J Immunol; 1983 Sep; 131(3):1481-6. PubMed ID: 6350456
[TBL] [Abstract][Full Text] [Related]
26. Characterization of human macrophage activation factor (MAF) prepared from antigen-stimulated lymphocytes.
Cameron DJ
J Clin Lab Immunol; 1984 Jan; 13(1):47-50. PubMed ID: 6371237
[TBL] [Abstract][Full Text] [Related]
27. Constitutive production of phagocytosis inducing factor(s) in a monocyte/macrophage lineage cell line (THP-1) by retrovirus-transformed human T cell lines.
Hinuma S; Sugamura K; Tsukamoto K; Hinuma Y
Microbiol Immunol; 1984; 28(8):935-47. PubMed ID: 6094992
[TBL] [Abstract][Full Text] [Related]
28. OKT3 monoclonal antibody induces production of colony-stimulating factor(s) for granulocytes and macrophages in cultures of human T lymphocytes and adherent cells.
Platzer E; Rubin BY; Lu L; Welte K; Broxmeyer HE; Moore MA
J Immunol; 1985 Jan; 134(1):265-71. PubMed ID: 3917276
[TBL] [Abstract][Full Text] [Related]
29. Lymphokine stimulation of human macrophage C2 production is partially due to interferon-gamma.
Sanders KM; Littman BH
J Immunol; 1986 Aug; 137(3):876-9. PubMed ID: 3088114
[TBL] [Abstract][Full Text] [Related]
30. Identification of a macrophage-activating factor in granules of the RNK large granular lymphocyte leukemia.
Roussel E; Greenberg AH
J Immunol; 1989 Jan; 142(2):543-8. PubMed ID: 2642945
[TBL] [Abstract][Full Text] [Related]
31. A serine proteinase inhibitor produced by an HTLV I virus-transformed human T lymphocyte line.
Ganea D; Cearlock D; Minowada J; Dray S
J Immunol; 1987 Feb; 138(4):1208-14. PubMed ID: 2433346
[TBL] [Abstract][Full Text] [Related]
32. Lymphokine production by human T cell hybridomas.
Le J; Vilcek J; Sadlik JR; Cheung MK; Balazs I; Sarngadharan MG; Prensky W
J Immunol; 1983 Mar; 130(3):1231-5. PubMed ID: 6401782
[TBL] [Abstract][Full Text] [Related]
33. Molecular mechanisms involved in T cell activation. II. The phosphatidylinositol signal-transducing mechanism mediates antigen-induced lymphokine production but not interleukin 2-induced proliferation in cloned cytotoxic T lymphocytes.
Kozumbo WJ; Harris DT; Gromkowski S; Cerottini JC; Cerutti PA
J Immunol; 1987 Jan; 138(2):606-12. PubMed ID: 3540124
[TBL] [Abstract][Full Text] [Related]
34. Intracellular destruction of Leishmania tropica by macrophages activated with macrophage activating factor/interferon.
Titus RG; Kelso A; Louis JA
Clin Exp Immunol; 1984 Jan; 55(1):157-65. PubMed ID: 6198115
[TBL] [Abstract][Full Text] [Related]
35. Immunopathological mechanisms of human T cell lymphotropic virus type 1 (HTLV-I) uveitis. Detection of HTLV-I-infected T cells in the eye and their constitutive cytokine production.
Sagawa K; Mochizuki M; Masuoka K; Katagiri K; Katayama T; Maeda T; Tanimoto A; Sugita S; Watanabe T; Itoh K
J Clin Invest; 1995 Feb; 95(2):852-8. PubMed ID: 7860769
[TBL] [Abstract][Full Text] [Related]
36. A novel human macrophage-activating factor: distinction from interferon-gamma (IFN-gamma) and granulocyte-macrophage colony-stimulating factor (GMCSF).
Jones MP; Gunapala DE; Matutes E; Catovsky D; Coates AR
Cell Immunol; 1988 May; 113(2):361-75. PubMed ID: 2834073
[TBL] [Abstract][Full Text] [Related]
37. Lymphokine-mediated induction of antigen-presenting ability in thymic stromal cells.
Ransom J; Fischer M; Mercer L; Zlotnik A
J Immunol; 1987 Oct; 139(8):2620-8. PubMed ID: 3116089
[TBL] [Abstract][Full Text] [Related]
38. Human non-interferon macrophage activating factor: biological and biochemical characterization.
Lee JC; Badger AM; Johnson WJ
Adv Exp Med Biol; 1988; 239():217-21. PubMed ID: 3264453
[TBL] [Abstract][Full Text] [Related]
39. A T cell-derived factor stimulating multipotential hemopoietic stem cells: molecular weight and distinction from T cell growth factor and T cell-derived granulocyte-macrophage colony-stimulating factor.
Schrader JW; Clark-Lewis I
J Immunol; 1982 Jul; 129(1):30-5. PubMed ID: 6979567
[TBL] [Abstract][Full Text] [Related]
40. Positively selected Lyt-2+ and Lyt-2- mouse T lymphocytes are comparable, after Con A stimulation, in release of IL 2 and of lymphokines acting on B cells, macrophages, and mast cells, but differ in interferon production.
Guerne PA; Piguet PF; Vassalli P
J Immunol; 1983 May; 130(5):2225-30. PubMed ID: 6187845
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
